Acurex Biosciences vs Lysoway Therapeutics
Acurex Biosciences vs Lysoway Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Acurex Biosciences is on 34/100 and Lysoway Therapeutics on 48/100.
Where each one leads
Acurex Biosciences
Leads on none of the measures we hold for both companies.
Lysoway Therapeutics
- our overall score: 48/100 against 34/100
- funding raised: $45.0M against $1.0M
At a glance
| Measure | Acurex Biosciences | Lysoway Therapeutics |
|---|---|---|
| What it is | Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders. | Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases. |
| Category | Biotechnology, Pharmaceuticals, Neuroscience, Healthcare | Biotechnology, Pharmaceuticals, Healthcare, Neuroscience |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2019 | 2021 |
| Headquarters | San Carlos, USA | Cambridge, USA |
| Status | Inactive | Inactive |
Size, funding and growth
| Measure | Acurex Biosciences | Lysoway Therapeutics |
|---|---|---|
| Total funding | $1.0M | $45.0M |
| Latest round | Grant | Series A |
| Valuation | Not published | $1.1B |
| LinkedIn followers | Not published | 1,282 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Acurex Biosciences | Lysoway Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 34/100 | 48/100 |
| Traction | 30/100 | 38/100 |
| Community | 15/100 | 15/100 |
| Search visibility | 18/100 | 20/100 |
| Quality | 45/100 | 68/100 |
Acurex Biosciences vs Lysoway Therapeutics: common questions
Which is better, Acurex Biosciences or Lysoway Therapeutics?
On our 0-100 score Lysoway Therapeutics rates higher (48/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Acurex Biosciences and Lysoway Therapeutics compare on the numbers?
Lysoway Therapeutics leads on our overall score (48/100 against 34/100), funding raised ($45.0M against $1.0M).
Read the full Acurex Biosciences review and pricing or the Lysoway Therapeutics review and pricing. You can also browse other Acurex Biosciences alternatives we track.